Microbial astaxanthin: from bioprocessing to the market recognition
Keywords: Astaxanthin · Microbial sources · Haematococcus pluvialis · Phaffia rhodozyma · Health · Upstream · Downstream · Market
Abstract
The attractive biological properties and health benefits of natural astaxanthin (AXT), including its antioxidant and anti-carcinogenic properties, have garnered significant attention from academia and industry seeking natural alternatives to synthetic products. AXT, a red ketocarotenoid, is mainly produced by yeast, microalgae, wild or genetically engineered bacteria. Unfortunately, the large fraction of AXT available in the global market is still obtained using non-environmentally friendly petrochemical-based products. Due to the consumers concerns about synthetic AXT, the market of microbial-AXT is expected to grow exponentially in succeeding years. This review provides a detailed discussion of AXT’s bioprocessing technologies and applications as a natural alternative to synthetic counterparts. Additionally, we present, for the first time, a very comprehensive segmentation of the global AXT market and suggest research directions to improve microbial production using sustainable and environmentally friendly practices.
Más información
Título de la Revista: | Applied Microbiology and Biotechnology |
Editorial: | Springer |
Fecha de publicación: | 2023 |
Página de inicio: | 1 |
Idioma: | English |
URL: | https://doi.org/10.1007/s00253-023-12586-1 |
DOI: |
10.1007/s00253-023-12586-1 |
Notas: | WOS |